BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Fu JF, Fang YL, Liang L, Wang CL, Hong F, Dong GP. A rabbit model of pediatric nonalcoholic steatohepatitis: The role of adiponectin. World J Gastroenterol 2009; 15(8): 912-918 [PMID: 19248189 DOI: 10.3748/wjg.15.912]
URL: https://www.wjgnet.com/1007-9327/full/v15/i8/912.htm
Number Citing Articles
1
Marc-Olivier Deguise, Chantal Pileggi, Yves De Repentigny, Ariane Beauvais, Alexandra Tierney, Lucia Chehade, Jean Michaud, Maica Llavero-Hurtado, Douglas Lamont, Abdelmadjid Atrih, Thomas M. Wishart, Thomas H. Gillingwater, Bernard L. Schneider, Mary-Ellen Harper, Simon H. Parson, Rashmi Kothary. SMN Depleted Mice Offer a Robust and Rapid Onset Model of Nonalcoholic Fatty Liver DiseaseCellular and Molecular Gastroenterology and Hepatology 2021; 12(1): 354 doi: 10.1016/j.jcmgh.2021.01.019
2
Ijin Joo, Jeong Min Lee, Jeong Hee Yoon, Ja Jun Jang, Joon Koo Han, Byung Ihn Choi. Nonalcoholic Fatty Liver Disease: Intravoxel Incoherent Motion Diffusion-weighted MR Imaging—An Experimental Study in a Rabbit ModelRadiology 2014; 270(1): 131 doi: 10.1148/radiol.13122506
3
Amalia E. Yanni, George Agrogiannis, Tzortzis Nomikos, Elisabeth Fragopoulou, Alkisti Pantopoulou, Smaragdi Antonopoulou, Despoina Perrea. Oral supplementation with l-aspartate and l-glutamate inhibits atherogenesis and fatty liver disease in cholesterol-fed rabbitAmino Acids 2010; 38(5): 1323 doi: 10.1007/s00726-009-0340-x
4
K Widhalm, E Ghods. Nonalcoholic fatty liver disease: a challenge for pediatriciansInternational Journal of Obesity 2010; 34(10): 1451 doi: 10.1038/ijo.2010.185
5
Mikhaïl Van Herck, Luisa Vonghia, Sven Francque. Animal Models of Nonalcoholic Fatty Liver Disease—A Starter’s GuideNutrients 2017; 9(10): 1072 doi: 10.3390/nu9101072
6
Ijin Joo, Jeong Min Lee, Jeong Hee Yoon, Ja Jun Jang, Joon Koo Han, Byung Ihn Choi. Nonalcoholic Fatty Liver Disease: Intravoxel Incoherent Motion Diffusion-weighted MR Imaging—An Experimental Study in a Rabbit ModelRadiology 2014; 270(1): 131 doi: 10.1148/radiol.13122506
7
Damien Chua, Zun Siong Low, Guo Xiang Cheam, Aik Seng Ng, Nguan Soon Tan. Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD ParadigmInternational Journal of Molecular Sciences 2022; 23(23): 14762 doi: 10.3390/ijms232314762
8
Beicheng Sun, Michael Karin. Obesity, inflammation, and liver cancerJournal of Hepatology 2012; 56(3): 704 doi: 10.1016/j.jhep.2011.09.020
9
Yan-Lan Fang, Hong Chen, Chun-Lin Wang, Li Liang. Pathogenesis of non-alcoholic fatty liver disease in children and adolescence: From “two hit theory” to “multiple hit model”World Journal of Gastroenterology 2018; 24(27): 2974-2983 doi: 10.3748/wjg.v24.i27.2974
10
Linqiang Zhang, Xiaoyun Wu, Shasha Liao, Yunhai Li, Zhiguo Zhang, Qing Chang, Ruyue Xiao, Bin Liang. Tree shrew (Tupaia belangeri chinensis), a novel non-obese animal model of non-alcoholic fatty liver diseaseBiology Open 2016; 5(10): 1545 doi: 10.1242/bio.020875
11
M A Hyatt, D S Gardner, S Sebert, V Wilson, N Davidson, Y Nigmatullina, L L Y Chan, H Budge, M E Symonds. Suboptimal maternal nutrition, during early fetal liver development, promotes lipid accumulation in the liver of obese offspringREPRODUCTION 2011; 141(1): 119 doi: 10.1530/REP-10-0325
12
Bo Yun Hur, Jeong Min Lee, Woo Hyunsik, Kyung Bun Lee, Ijin Joo, Joon Koo Han, Byung Ihn Choi. Quantification of the Fat Fraction in the Liver Using Dual-Energy Computed Tomography and Multimaterial DecompositionJournal of Computer Assisted Tomography 2014; 38(6): 845 doi: 10.1097/RCT.0000000000000142
13
Yasutaka Baba, Sadao Hayashi, Kohei Nagasato, Michiyo Higashi, Nanako Tosuji, Shunro Sonoda, Takashi Yoshiura. Oxidative stress induced by portal vein embolization in fatty liver: Experimental study of a nonalcoholic steatohepatitis modelBiomedical Reports 2018;  doi: 10.3892/br.2018.1141
14
Barbara L. Oglesbee. Exotic Animal Laboratory Diagnosis2020; : 63 doi: 10.1002/9781119108610.ch5
15
Tomohiro Ogawa, Hideki Fujii, Katsutoshi Yoshizato, Norifumi Kawada. A Human-Type Nonalcoholic Steatohepatitis Model with Advanced Fibrosis in RabbitsThe American Journal of Pathology 2010; 177(1): 153 doi: 10.2353/ajpath.2010.090895
16
Sheila Cristina L. Sanches, Leandra Naira Z. Ramalho, Marlei Josiele Augusto, Deisy Mara da Silva, Fernando Silva Ramalho. Nonalcoholic Steatohepatitis: A Search for Factual Animal ModelsBioMed Research International 2015; 2015: 1 doi: 10.1155/2015/574832
17
Mário Cláudio Soares Sturzeneker, Sergio Ossamu Ioshii, Liz Andréa Villela Baroncini, Dalton Bertolim Précoma. Olmesartan severely weakened the development of NASH in an animal model of hypercholesterolemiaAtherosclerosis 2011; 216(1): 97 doi: 10.1016/j.atherosclerosis.2011.01.047
18
Cai-Yu Lian, Zhen-Zhen Zhai, Zi-Fa Li, Lin Wang. High fat diet-triggered non-alcoholic fatty liver disease: A review of proposed mechanismsChemico-Biological Interactions 2020; 330: 109199 doi: 10.1016/j.cbi.2020.109199
19
Ahmed Abu Shanab, Paul Scully, Orla Crosbie, Martin Buckley, Liam O’Mahony, Fergus Shanahan, Sanaa Gazareen, Eileen Murphy, Eamonn M. M. Quigley. Small Intestinal Bacterial Overgrowth in Nonalcoholic Steatohepatitis: Association with Toll-Like Receptor 4 Expression and Plasma Levels of Interleukin 8Digestive Diseases and Sciences 2011; 56(5): 1524 doi: 10.1007/s10620-010-1447-3
20
Veronica Marin, Natalia Rosso, Matteo Dal Ben, Alan Raseni, Manuela Boschelle, Cristina Degrassi, Ivana Nemeckova, Petr Nachtigal, Claudio Avellini, Claudio Tiribelli, Silvia Gazzin, Anna Alisi. An Animal Model for the Juvenile Non-Alcoholic Fatty Liver Disease and Non-Alcoholic SteatohepatitisPLOS ONE 2016; 11(7): e0158817 doi: 10.1371/journal.pone.0158817